For the past few years, the stem cell technology has been surrounded by a lot of buzz in the research world for its ability to improve the functionality of any part of the human body including tissues, organs, and nerves and stimulate the restoration mechanisms of a living organ to rebuild damaged tissues and organs.
Though still in its nascent stages, The Global Stem Cell Products Market has already witnessed impressive growth and is expected to rise rapidly thanks to a few key drivers:
- Increase in Sales of Regenerative Medicines
- Increase in Applications in Skin/Integumentary Therapies
- Increased Focus on Angiogenesis
Considering these developments, our TechNavio analysts confidently predict that the stem cell market will soar at a CAGR of 12.17 percent for the next few years approaching a market value of $US 6.57 billion by 2016. With such a huge sum in the forecast, it’s natural that established vendors are racing to cover all their bases and investing heavily in R and D to claim patents for stem cell applications before their competitors.
Despite the huge scope of opportunity however, the fact remains that cell-based biologic applications are still in a state of extreme infancy, especially from commercial perspective. While the potential for profit is undeniable, there’s no real way of telling what kind of business model will eventually emerge from the market, specifically in terms of vendor landscape.
Our prediction is that the next few years will see a huge boom in mergers and acquisitions as developers and suppliers collaborate by sharing research and patents to reduce costs, increase global presence and bring in more revenue from the stem cell market. Otherwise, it will be very challenging for smaller companies-and even some larger enterprises-to cash in on stem cells considering the high development costs for licensing, acquisitions, marketing, and manufacturing.
Taking all this into consideration, it seems safe to say that although the potential for profit in The Global Stem Cell Products Market is firmly established, the matter of who will take home the biggest share of the stem cell sweepstakes is far from being set in stone.
For more info, view our 2012-2016 report on The Global Stem Cell Products Market.
Other Related Reports:
Global Vascular Stents Market 2012-2016
Global Dental Implants Market 2012-2016
